Sight Sciences, Inc. SGHT Surgical Glaucoma — Cost of Goods Sold
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sight Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold?
- Sight Sciences, Inc. (SGHT) reported surgical glaucoma — cost of goods sold of $2.34M in Q1 2026.
- How has Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold changed year-over-year?
- Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold increased by 1.9% year-over-year, from $2.3M to $2.34M.
- What is the long-term trend for Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold?
- Over 4 years (2021 to 2025), Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold has grown at a 11.6% compound annual growth rate (CAGR), from $6.47M to $10.03M.
- What does surgical glaucoma — cost of goods sold mean?
- This metric captures the direct costs incurred to manufacture and deliver the surgical glaucoma products and services, including materials, labor, and overhead directly attributable to production. Monitoring this figure is essential for assessing the direct production efficiency and the impact of supply chain costs on the segment's profitability. Changes in this metric relative to revenue can indicate shifts in manufacturing scale or input cost inflation.